| 2026 | A prospective study for brain metastasis imaging screening in patients with advanced HER2-positive or triple-negative breast cancer
| ESMO OPEN |
| 2026 | Improved tumor control with adjuvant radiotherapy in patients with central neurocytoma: a multicenter study | JOURNAL OF NEURO-ONCOLOGY |
| 2026 | Intraoperative Visual Evoked Potential Monitoring in Endoscopic Endonasal Surgery for Nonpituitary Adenoma Suprasellar Tumors
| JOURNAL OF CLINICAL NEUROLOGY |
| 2026 | Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients
| JOURNAL OF NEURO-ONCOLOGY |
| 2026 | Two-Week Interval Hypofractionated Stereotactic Radiosurgery for Benign Intracranial Tumors: Volumetric Kinetics and Radiobiological Rationale
| CANCERS |
| 2026 | Safety and efficacy of stereoelectroencephalography using a novel robot based on the center-of-arc principle in patients with medically refractory epilepsy | JOURNAL OF NEUROSURGERY |
| 2026 | Portable duplex digital PCR for on-site detection of IDH mutations in gliomas | BIOSENSORS & BIOELECTRONICS |
| 2026 | IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation | SCIENCE |
| 2026 | Pharmacological transglutaminase 2 inhibition enhances temozolomide response in patient-derived glioblastoma tumorspheres | JOURNAL OF NEURO-ONCOLOGY |
| 2026 | Tumor Control After Radiosurgery in Sporadic and Neurofibromatosis Type 2 Vestibular Schwannomas
| CANCER MEDICINE |
| 2026 | The new Bruton's tyrosine kinase inhibitors SPA8007 and SPA8009 reduce stemness and invasiveness of patient-derived glioblastoma tumorspheres
| TRANSLATIONAL ONCOLOGY |
| 2026 | Revisiting prognosis of oligodendroglioma patients in the 2021 WHO classification: incremental value of imaging features | EUROPEAN RADIOLOGY |
| 2025 | Restoring the glioblastoma tumor microenvironment by targeting C5a with the antagonist W54011
| SCIENTIFIC REPORTS |
| 2025 | Predicting molecular types of adult-type diffuse gliomas based on MRI reports with large language models | EUROPEAN RADIOLOGY |
| 2025 | Clinical and molecular characteristics and prognostic factors of diffuse astrocytoma, IDH-wildtype, not elsewhere classified | JOURNAL OF NEURO-ONCOLOGY |
| 2025 | A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group
| LANCET ONCOLOGY |
| 2025 | Neoadjuvant gamma knife surgery for metastatic brain tumor: clinical use and impact on leptomeningeal seeding | JOURNAL OF NEURO-ONCOLOGY |
| 2025 | The concept, intention, and evaluation of the term treatment-refractory meningioma
| JOURNAL OF NEURO-ONCOLOGY |
| 2025 | Co-blockade of TGFβ and PD-1 Reinvigorates Glioblastoma-Infiltrating CD8+ T Cells That Characteristically Upregulate TGFβRI Expression | CLINICAL CANCER RESEARCH |
| 2025 | Leptomeningeal metastases at recurrence in IDH-wildtype glioblastomas: incidence, risk factors, and prognosis based on postcontrast FLAIR imaging | EUROPEAN RADIOLOGY |
| 2025 | Comparison of the biological characteristics of glioblastoma tumorspheres obtained from fresh and cryopreserved glioblastoma tissues | JOURNAL OF NEURO-ONCOLOGY |
| 2025 | Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge
| NATURE COMMUNICATIONS |
| 2025 | Precancerous Cells Initiate Glioblastoma Evolution and Contribute to Intratumoral Heterogeneity | CANCER DISCOVERY |
| 2025 | Tumor suppressive effect of low-frequency repetitive transcranial magnetic stimulation on glioblastoma progression
| NEUROTHERAPEUTICS(Neurotherapeutics) |
| 2025 | Tumor oxygenation imaging biomarkers using dynamic susceptibility contrast imaging for prediction of IDH mutation status in adult-type diffuse gliomas | EUROPEAN RADIOLOGY |
| 2025 | N-phenylmaleimide induces bioenergetic switch and suppresses tumor growth in glioblastoma tumorspheres by inhibiting SLC25A11
| CANCER CELL INTERNATIONAL |
| 2025 | A Neuroimmune-Oncology Microphysiological Analysis Platform (NEO-MAP) for Evaluating Astrocytic Scar Formation and Microgliosis in Glioblastoma Microenvironment | ADVANCED HEALTHCARE MATERIALS |
| 2025 | A novel variant of telomerase reverse transcriptase (TERT) associated with risk of glioma in a Korean population
| SCIENTIFIC REPORTS |
| 2025 | Differences in Treatment Outcomes Depending on the Adjuvant Treatment Modality in Craniopharyngioma
| YONSEI MEDICAL JOURNAL |
| 2025 | Interpretable multimodal transformer for prediction of molecular subtypes and grades in adult-type diffuse gliomas
| NPJ DIGITAL MEDICINE(Nature partner journals digital medicine Digital medicine) |
| 2025 | Distant origin of glioblastoma recurrence: neural stem cells in the subventricular zone serve as a source of tumor reconstruction after primary resection
| MOLECULAR CANCER |
| 2025 | To Use or Not to Use: Temozolomide in Elderly Patients with IDH Wild-Type MGMT Promoter Unmethylated Glioblastoma Treated with Radiotherapy
| CANCER RESEARCH AND TREATMENT |
| 2025 | A comprehensive multicenter analysis of clinical, molecular, and imaging characteristics and outcomes of H3 K27-altered diffuse midline glioma in adults | JOURNAL OF NEUROSURGERY |
| 2025 | Disruption of bioenergetics enhances the radio-sensitivity of patient-derived glioblastoma tumorspheres
| TRANSLATIONAL ONCOLOGY |
| 2024 | Incorporating supramaximal resection into survival stratification of IDH-wildtype glioblastoma: a refined multi-institutional recursive partitioning analysis | CLINICAL CANCER RESEARCH |
| 2024 | Deep learning-driven macroscopic AI segmentation model for brain tumor detection via digital pathology: Foundations for terahertz imaging-based AI diagnostics
| HELIYON |
| 2024 | Synergistic combination of perphenazine and temozolomide suppresses patient-derived glioblastoma tumorspheres | NEURO-ONCOLOGY |
| 2024 | Leptomeningeal metastases in isocitrate dehydrogenase-wildtype glioblastomas revisited: Comprehensive analysis of incidence, risk factors, and prognosis based on post-contrast fluid-attenuated inversion recovery | NEURO-ONCOLOGY |
| 2024 | Identification of prognostic imaging biomarkers in H3 K27-altered diffuse midline gliomas in adults: impact of tumor oxygenation imaging biomarkers on survival | NEURORADIOLOGY |
| 2024 | Revisiting oligodendroglioma grading in the 2021 WHO classification: calcification and larger contrast-enhancing tumor volume may predict higher oligodendroglioma grade | NEURORADIOLOGY |
| 2024 | Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance | JOURNAL OF NEURO-ONCOLOGY |
| 2024 | Revisiting gliomatosis cerebri in adult-type diffuse gliomas: a comprehensive imaging, genomic and clinical analysis
| ACTA NEUROPATHOLOGICA COMMUNICATIONS |
| 2024 | Nomogram for radiation-induced lymphopenia in patients receiving intensity-modulated radiotherapy based-chemoradiation therapy for newly diagnosed glioblastoma: A multi-institutional study
| CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY |
| 2024 | Revisiting prognostic factors of gliomatosis cerebri in adult-type diffuse gliomas | JOURNAL OF NEURO-ONCOLOGY |
| 2024 | Diffusion- and Perfusion-Weighted MRI Radiomics for Survival Prediction in Patients with Lower-Grade Gliomas
| YONSEI MEDICAL JOURNAL |
| 2024 | Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironment | NEURO-ONCOLOGY |
| 2024 | Comparison of Glioblastoma Cell Culture Platforms Based on Transcriptional Similarity with Paired Tissue
| PHARMACEUTICALS |
| 2024 | Clinical, qualitative imaging biomarkers, and tumor oxygenation imaging biomarkers for differentiation of midline-located IDH wild-type glioblastomas and H3 K27-altered diffuse midline gliomas in adults | EUROPEAN JOURNAL OF RADIOLOGY |
| 2024 | The importance of considering competing risks in recurrence analysis of intracranial meningioma
| JOURNAL OF NEURO-ONCOLOGY |
| 2024 | Rethinking extent of resection of contrast-enhancing and non-enhaning tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification | EUROPEAN RADIOLOGY |
http://orcid.org/0000-0003-1509-9800
(7601549862)
